VOGX

Vogenx Inc

14.78

Aug 14 • 3:59 PM ET +0.69 (4.90%)

14.78

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Micro NASD

Aug 13, 4:40 PMVogenx Inc announces the closing of its initial public offering of 6,250,000 shares at $13.00 per share, raising approximately $81.3 million in gross proceeds.

Scroll to Statements

Index	-
Market Cap	205.74M
Enterprise Value	206.33M
Income	-
Sales	-
Book/sh	-0.10
Cash/sh	0.02
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Aug 12, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	822.95
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.11
Current Ratio	0.11
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / No

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	5.90%
SMA50	5.90%
SMA200	5.90%
Trades

Shs Outstand	13.92M
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	14.20 4.07%
52W Low	12.95 14.13%
Volatility	- -
ATR (14)	1.76
RSI (14)	-
Beta	-
Rel Volume	0.10
Avg Volume	382.50K
Volume	37,243

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	13.69%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	14.09
Price	14.78
Change %	4.90%

Aug-13-26 04:35PM

Vogenx Announces Closing of Initial Public Offering

(ACCESSWIRE) +8.38%

Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VOGX

Vogenx Inc

Upgrade your Finviz experience